These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16537682)

  • 1. Ghrelin potentiates growth hormone secretion driven by putative somatostatin withdrawal and resists inhibition by human corticotropin-releasing hormone.
    Veldhuis JD; Iranmanesh A; Mielke K; Miles JM; Carpenter PC; Bowers CY
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2441-6. PubMed ID: 16537682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative somatostatin suppression potentiates adrenocorticotropin secretion driven by ghrelin and human corticotropin-releasing hormone.
    Iranmanesh A; Carpenter PC; Mielke K; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3653-9. PubMed ID: 17566099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5484-9. PubMed ID: 14602794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women.
    Veldhuis JD; Keenan DM; Iranmanesh A; Mielke K; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3559-65. PubMed ID: 16804038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
    Veldhuis JD; Anderson SM; Patrie JT; Bowers CY
    J Clin Endocrinol Metab; 2004 Jan; 89(1):121-7. PubMed ID: 14715838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
    Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting negative-feedback control of endogenously driven and exercise-stimulated pulsatile growth hormone secretion in women and men.
    Veldhuis JD; Patrie J; Wideman L; Patterson M; Weltman JY; Weltman A
    J Clin Endocrinol Metab; 2004 Feb; 89(2):840-6. PubMed ID: 14764803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
    Veldhuis JD; Norman C; Miles JM; Bowers CY
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4753-60. PubMed ID: 22990092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults.
    Soares-Welch C; Farhy L; Mielke KL; Mahmud FH; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2225-32. PubMed ID: 15634714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
    Racine MS; Symons KV; Foster CM; Barkan AL
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-like potentiation of ghrelin-stimulated GH secretion by fulvestrant, a putatively selective ER antagonist, in postmenopausal women.
    Veldhuis JD; Yang RJ; Wigham JR; Erickson D; Miles JC; Bowers CY
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2557-64. PubMed ID: 25210881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
    Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
    Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
    Broglio F; Benso A; Gottero C; Prodam F; Grottoli S; Tassone F; Maccario M; Casanueva FF; Dieguez C; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):265-71. PubMed ID: 12153607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men.
    Koutkia P; Canavan B; Breu J; Johnson ML; Grinspoon SK
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E506-12. PubMed ID: 15138154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term estradiol supplementation potentiates low-dose ghrelin action in the presence of GHRH or somatostatin in older women.
    Norman C; Rollene N; Weist SM; Wigham JR; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E73-80. PubMed ID: 24203062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.